| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vvi16g1217 | ATGAAGGCTTTCGTCTCTTCCTTTTTGCTCTACACAGTCCTGTTGTGCATCCATCTATGGCGTCCCGTCACTGCCAGTAGCATGCAAAACGAAACAGATCGACTTGCGTTGATTGCTTTCAAGGATGGAATCACCCAGGATCCACTTGGGATGCTGAGTTCTTGGAATGACTCGCTCCACTTTTGCCGGTGGTCAGGAGTGTATTGCAGTCGCAGGCATGTCCACAGAGTCACCAAATTAAATCTCTTTTCTTATGGACTGGTGGGATCCCTCTCACCCCATATCGGGAACCTCACCTTTCTTAGAACAATAGTCCTCCAAAATAACAGCTTCCATGGCAAAGTGCCTTCTGAGATCGGTGGTTTGTTCCGCCTACAAGTTCTTGTTCTTAGCAACAATTCCTTTGAAGGAAAGGTCCCTACCAATCTGACATATTGCTCAGAGCTTAGGGTCCTTAATCTAATCGACAACAAGCTTGAAGGCAAAATCCCAGAAGAACTTGGCTCCCTCTCAAAATTGAAAGCTCTGGGTCTCACTAGGAACAATCTCACAGGAAAGATCCCAGCTTCACTCGGGAACCTCTCATCTCTCAGTCTTTTTTCTGCAATGTACAACAGTCTGGAAGGAAGCATTCCTGAGGAGATTGGTAGAACAAGTATAGATTGGCTTCACTTAGGTTTCAACAGATTAACAGGTACGATTCCATCTTCTCTGTACAATCTCTCAAACATGTATTACTTCCTAGTTGGAGCTAACCAACTAGAGGGAAGCCTTAGTCAGGATATGGGTGTTGCCTTTCCTCATCTCAGGATGCTAGTTCTTGCAGAAAACCGATTCACAGGGCCTGTTCCCGTTTCATTATCTAATGCTTCAATGCTTGAAGCTATCTATGCCCCTGATAACAGTTTCACTGGGCCAGTACCACCAAATTTGGGGAGGCTGCAAAATCTTCGAGATATAACCATGGGCTGGAATCAGTTGGGTTCTGCCGGAGGAGATGATTTGAGCTTCATTAATTCTCTAGCAAACTGCACTTGGTTACAAAGAATGTCTTTCAGCCGCAATTTTCTCAAAGGTCCTTTGGTTAGCACAATAGCTAATTTCTCGACCCAAATTTCTTTGATAGATCTGGGAATCAACCAGATTCATGGAACAATTCCTTCAGGAATCAAGAACCTGGTAAATCTAACATTCTTGAACTTGGCTAGGAATCATCTCACCGGGAGCATTCCTTCCAATATTGGAAAGCTCTATAAAATACAAGTACTACTTTTGCTTGGAAACAGACTCTCCGGAATAATACCATCCTCACTCGGTAACTTAACCTTGTTGAATAATCTTGATTTAAGCGGCAACAACTTGATGGGAGAAATACCTTCCAGTCTAGCAGCCTGTCAAATCCTAGCACAATTGAGACTTTCTAACAACAACCTTAATGGTTCAATCCCAACAGAACTTATGGGTCATTTCTCGCTTGTGGTCCTGCAATTGGGTGGCAACGCCTTTACGGGTTCGCTGCCATTGGAAGTTGGCCATATGATTAACCTTGAAGTGTTAGATGTCTCTGAAAGCAGATTATCAAGTGGTCTTCCAAACACTTTAGGTAACTGTGTGGTAATGCGGGATCTTCGACTTACTGGTAATTTCTTTGAAGGAGAGATTCCCACATCGCTGCAAACTCTTCGAGGTTTAGAATACTTGGATCTTTCTCGCAACAAATTTTCTGGTAGGATCCCGATGTTTCTTGGGGACCTTCCTTTCTTGACCTATTTGAACTTGTCTTTCAATGAACTTGAAGGAGAAGTACCCTCAGTCAAGGCCAATGTCACAATTTCAGTTGAAGGAAACTATAATCTTTGTGGAGGCGTTCCCAAGCTTCATCTTCCCATATGTGTCACCTCATCTACTGGCGAAAAGAGGAAGCGTCCTGCTGCCAAACTACTCGTTCCGGTAATCATTGGAATTACATCCTTGAGTTTGTTGGCTTTCTTCGTTATTATCCTTCTGAGAAGAAAAAAATCGAGGAATGATGTCTCTTACACACAATCATTCAACAATCAATTCCTAAGAATTTCATTCGCAGACCTCCATAAAGCTACTGAAGGCTTCTCCGAGTCCAATATGATCGGTGTTGGGAGCTACGGTTCTGTGTATAAAGGAATCCTTGATCAAAATGGAACAGCTATTGCAGTAAAGGTGTTCAATCTTCCCCGAGGAGCTTCCAAGAGCTTTATGTCCGAATGCAAGGCCTTGAGAAAAATCCGGCATAAGAATCTTGTCAAAGTCTTGAGTGCTTGCTCTAGCTTGGACTTTCAGGGTAATGATTTCAAGGCTCTTGTGTTTGAGTTGATGCCACAAGGGAATTTGGATGGATGGTTACATCCAGAAGTAAGAGAGGATGAACCCCAAAGGCTTACCCTTCTACAGAGACTGAATATCGCTATTGACGTTGCTTCAGCACTGGAGTATCTTCACACTCAATGTGATGACATTATTGTTCATAATGATCTTAAGCCCAGCAATGTTCTTCTTGACAATGATATGATGGGCCATATCGGTGATTTTGGTATTGCAAAGATCACTTCTGTTGTTTTCAGCACTACAATTGCTACTAGTGTTGGCACAGACCAAAATACCTCGAATGCAGTGAAAGGATCCATAGGCTACATTGCTCCAGAATATGGTGTGAGTGGCAAGGTGTCCACTGAGGGAGATGTGTATAGTTATGGAATCCTTTTATTGGAGATGTTTACCGGAAGAAGACCAACTGATAACAAGTTCCAAGATGGTCATACTCTTCATAGCTTCGTGAAAACGTCTTTGCCTGAGCGAGTCATGGAGGTCATAGATCAGCCTTTGCTTTTAGAGGCAGATGAAAGAGGTAAAATGAGGGAATGCATCATTGCAGTATTGCGAATCGGCATCACTTGTTCCATGGAATCACCAAAAGACCGAATGGAGATAGGTGACGCAGCCAATAAATTACACTCAATCAAGAACCTCTTCTTAAGGGAGGCGGGTCATGGATAG | 3030 | 0.431 | MKAFVSSFLLYTVLLCIHLWRPVTASSMQNETDRLALIAFKDGITQDPLGMLSSWNDSLHFCRWSGVYCSRRHVHRVTKLNLFSYGLVGSLSPHIGNLTFLRTIVLQNNSFHGKVPSEIGGLFRLQVLVLSNNSFEGKVPTNLTYCSELRVLNLIDNKLEGKIPEELGSLSKLKALGLTRNNLTGKIPASLGNLSSLSLFSAMYNSLEGSIPEEIGRTSIDWLHLGFNRLTGTIPSSLYNLSNMYYFLVGANQLEGSLSQDMGVAFPHLRMLVLAENRFTGPVPVSLSNASMLEAIYAPDNSFTGPVPPNLGRLQNLRDITMGWNQLGSAGGDDLSFINSLANCTWLQRMSFSRNFLKGPLVSTIANFSTQISLIDLGINQIHGTIPSGIKNLVNLTFLNLARNHLTGSIPSNIGKLYKIQVLLLLGNRLSGIIPSSLGNLTLLNNLDLSGNNLMGEIPSSLAACQILAQLRLSNNNLNGSIPTELMGHFSLVVLQLGGNAFTGSLPLEVGHMINLEVLDVSESRLSSGLPNTLGNCVVMRDLRLTGNFFEGEIPTSLQTLRGLEYLDLSRNKFSGRIPMFLGDLPFLTYLNLSFNELEGEVPSVKANVTISVEGNYNLCGGVPKLHLPICVTSSTGEKRKRPAAKLLVPVIIGITSLSLLAFFVIILLRRKKSRNDVSYTQSFNNQFLRISFADLHKATEGFSESNMIGVGSYGSVYKGILDQNGTAIAVKVFNLPRGASKSFMSECKALRKIRHKNLVKVLSACSSLDFQGNDFKALVFELMPQGNLDGWLHPEVREDEPQRLTLLQRLNIAIDVASALEYLHTQCDDIIVHNDLKPSNVLLDNDMMGHIGDFGIAKITSVVFSTTIATSVGTDQNTSNAVKGSIGYIAPEYGVSGKVSTEGDVYSYGILLLEMFTGRRPTDNKFQDGHTLHSFVKTSLPERVMEVIDQPLLLEADERGKMRECIIAVLRIGITCSMESPKDRMEIGDAANKLHSIKNLFLREAGHG* | 1010 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vvi16g1217 | 1009 | SMART | serkin_6 | 703 | 971 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi16g1217 | 1009 | Pfam | Leucine rich repeat | 124 | 183 | IPR001611 | GO:0005515 | |
| Vvi16g1217 | 1009 | ProSiteProfiles | Protein kinase domain profile. | 703 | 971 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi16g1217 | 1009 | FunFam | Leucine-rich repeat receptor-like protein kinase | 30 | 189 | - | - | |
| Vvi16g1217 | 1009 | SUPERFAMILY | L domain-like | 370 | 620 | - | - | |
| Vvi16g1217 | 1009 | FunFam | LRR receptor-like serine/threonine-protein kinase EFR | 674 | 783 | - | - | |
| Vvi16g1217 | 1009 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 784 | 1007 | - | - | |
| Vvi16g1217 | 1009 | Gene3D | Ribonuclease Inhibitor | 202 | 336 | IPR032675 | - | |
| Vvi16g1217 | 1009 | Gene3D | Ribonuclease Inhibitor | 30 | 190 | IPR032675 | - | |
| Vvi16g1217 | 1009 | ProSitePatterns | Protein kinases ATP-binding region signature. | 709 | 732 | IPR017441 | GO:0005524 | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 441 | 465 | IPR003591 | - | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 513 | 537 | IPR003591 | - | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 122 | 146 | IPR003591 | - | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 393 | 417 | IPR003591 | - | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 170 | 194 | IPR003591 | - | |
| Vvi16g1217 | 1009 | SMART | LRR_typ_2 | 561 | 583 | IPR003591 | - | |
| Vvi16g1217 | 1009 | Gene3D | Phosphorylase Kinase; domain 1 | 665 | 782 | - | - | |
| Vvi16g1217 | 1009 | PANTHER | LEUCINE RICH REPEAT FAMILY PROTEIN, EXPRESSED | 222 | 997 | - | - | |
| Vvi16g1217 | 1009 | Gene3D | Transferase(Phosphotransferase) domain 1 | 784 | 1005 | - | - | |
| Vvi16g1217 | 1009 | Pfam | Leucine rich repeat N-terminal domain | 31 | 70 | IPR013210 | - | |
| Vvi16g1217 | 1009 | Gene3D | Ribonuclease Inhibitor | 337 | 639 | IPR032675 | - | |
| Vvi16g1217 | 1009 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 832 | 844 | IPR008271 | GO:0004672|GO:0006468 | |
| Vvi16g1217 | 1009 | Pfam | Protein kinase domain | 704 | 938 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi16g1217 | 1009 | FunFam | LRR receptor-like serine/threonine-protein kinase EFR | 333 | 637 | - | - | |
| Vvi16g1217 | 1009 | SUPERFAMILY | Protein kinase-like (PK-like) | 676 | 995 | IPR011009 | - | |
| Vvi16g1217 | 1009 | SUPERFAMILY | L domain-like | 29 | 327 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vvi16g1217 | Vvi-Chr16 | 20848483 | 20851612 | Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vvi16g1217 | 30 | 1006 | Receptor kinase-like Gene Family | AT3G47570 | 44.456 | 0.0 | 792 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XII-1 | Vvi16g1217 | Pkinase | 6.6e-39 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vvi16g1217 | - | - | vvi:100265904 | 1795.79 |